James C. Czirr - 31 Dec 2024 Form 5 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
10%+ Owner
Signature
/s/ James C. Czirr
Issuer symbol
GALT
Transactions as of
31 Dec 2024
Net transactions value
+$12,000
Form type
5
Filing time
11 Jun 2025, 17:18:21 UTC
Previous filing
25 Apr 2024
Next filing
11 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CZIRR JAMES C 10%+ Owner 4908 S. ASHTON CT., SPOKANE, /s/ James C. Czirr 11 Jun 2025 0001260641

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Other $6,000 +1,000 +0.13% $6.00 763,616 31 Mar 2024 Direct F1, F2
transaction GALT Common Stock Gift -4,400 -0.58% 759,216 10 May 2024 Direct F3
transaction GALT Common Stock Gift -4,400 -0.58% 754,816 17 May 2024 Direct F3
transaction GALT Common Stock Gift -4,400 -0.58% 750,416 17 May 2024 Direct F3
transaction GALT Common Stock Gift -4,400 -0.59% 746,016 26 Jun 2024 Direct F3
transaction GALT Common Stock Other $6,000 +1,000 +0.13% $6.00 747,016 30 Sep 2024 Direct F1, F2
transaction GALT Common Stock Gift -600 -0.08% 746,416 03 Jul 2024 Direct F3
transaction GALT Common Stock Gift -5,000 -0.67% 741,416 19 Dec 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Common stock received in satisfaction of $6,000 of dividends due on Series A Convertible Preferred Stock owned by James C. Czirr pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividends were payable on 3/31/2024 and 9/30/2024. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend.
F2 Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9.
F3 No consideration was received for the shares, which were transferred by gift to relatives.